1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Joint MRC Clinical Research Training Fellowships is sponsored by Medical Research Council (MRC) & Prostate Cancer UK. Offers clinical research training fellowships in partnership with Prostate Cancer UK to clinically active healthcare professionals who wish to undertake a PhD or reacquire skills after time away from research, specifically in prostate cancer research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Joint MRC Clinical Research Training Fellowships | Prostate Cancer UK Research webinars for supporters Meet our Funding Committees UK Prostate Cancer Clinical Research Strategy Group Career Acceleration Fellowships Research Innovation Awards Transformational Impact Awards Joint MRC Clinical Research Training Fellowships Starter Grants for Clinical Lecturers Frequently Asked Questions Real-World Evidence for Health Equity in Prostate Cancer Awards Funding Terms & Conditions Trailfinders Prostate Cancer UK Senior Clinical Fellowship in Medical Oncol...
Windsor Fellowship - Prostate Cancer UK Internship Programme Joint PCF Young Investigator Awards Joint MRC Clinical Research Training Fellowships Joint MRC Clinical Research Training Fellowships Introduction - Call Deadline: 4pm, 2 September 2026 Prostate Cancer UK is committed to supporting innovative research of the highest scientific quality, by providing funding for researchers.
We’re offering clinical research training fellowships in partnership with the Medical Research Council (MRC) to researchers with a clinical background, who wish to undertake a PhD or reacquire skills after time away from research. The Clinical Research Training Fellowship (CRTF) scheme supports clinically active healthcare professionals to undertake a higher research degree, such as a PhD or MD in prostate cancer research.
It can also provide post-doctoral funding for those who attained their PhD over five years ago and who now wish to consolidate and refresh their research skills. Valuable funding for salaries and consumables is offered under both fellowships. More details of this scheme are on the MRC website .
To apply for Prostate Cancer UK joint funding, please make sure you type Prostate Cancer UK in the Joint Funders box within the application form. Applications to the CRTF schemes below are open to registered healthcare professionals, including but not limited to GPs, pharmacists and allied healthcare professionals. The awards are managed by the MRC.
For specific details on the fellowship opportunities available, please see below. Find information on how to apply .
To be eligible for the professional doctorate clinical research training fellowship funding you must: Be planning to undertake a PhD or similar higher research degree Be at an appropriate point in your clinical training to study for a PhD, with clear plans for completing your speciality training Be able to demonstrate ownership of your project and show ambition to follow a clinical academic career linked to prostate cancer research Funding for your salary is covered by the award and 100% of the justified project costs for up to three years.
Professional doctorate: clinical research training fellowship – UKRI CTRFs offer the possibility of joint funding with us. Simply add ’Prostate Cancer UK’ into the joint-funding box where prompted on the application form. Applications for joint funding should fit within the scope of our Research Strategy .
A joint-funded CRTF application may offer additional opportunities to report on your project, present your work at meetings and take part in professional networking. As an early career researcher, you’ll also be invited to our Making Progress and From Ideas to Innovation events which provide opportunities to establish future collaborations within the scientific community.
Find out more about Making Progress LAUNCH : Call opens for applications 10 June 2026 DEADLINE : Call closes 2 September 2026 (16:00hrs) SHORTLISTING: February 2027 DECISION MEETING: 17 to 18 March 2027 NOTIFICATION: Applicants will be notified as to the outcome of their submission within 10 working days of funding decision meeting Opens: 21 October 2026, Closes: 13 January 2027 Opens: 14 January 2027, Closes: 7 April 2027 Opens: 10 June 2027, Closes: 2 September 2027 Dr Joaquin Mateo – Treatment of prostate cancer patients with changes to their DNA repair genes Dr Deborah Enting – Using the body’s immune system to fight prostate cancer If you have any questions about eligibility or would like to discuss an application, please email the MRC at [email protected]
According to the current listing, eligibility includes: Registered healthcare professionals planning to undertake a PhD or similar higher research degree, or post-doctoral researchers seeking to consolidate skills. Confirm the full requirements in the official notice before applying.
The current listing shows covers salary and 100% of justified project costs for up to three years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 2, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Joint MRC Clinical Research Training Fellowships is funded by Medical Research Council (MRC) & Prostate Cancer UK. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article